Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron King

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Theoretical Biology|December 19, 2009
Consequential classes of resources: Subtle global bifurcation with dramatic ecological consequences in a simple population modelJohn Vandermeer, Aaron King
Clinical Diabetes : a Publication of the American Diabetes Association|April 24, 2023
Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes-So Why Is Their Uptake So Low?Aaron King, Eden M Miller
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 7, 2023
Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP-4i) in US Adults with Type 2 DiabetesXi Tan, Yuanjie Liang, Cory Gamble, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|December 24, 2025
Management of Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease Risk in People With Type 2 Diabetes: Collaborative Care Plans for Primary Care Physicians Using Effective Communication StylesCarlos Campos, Aaron King, Eden Miller, et al.
Postgraduate Medicine|September 30, 2024
Advances in insulin: a review of icodec as a novel once-weekly treatment for type 2 diabetesJavier Morales, Aaron King, Sean Oser, et al.
Annals of Medicine|June 29, 2021
Leveraging advances in diabetes technologies in primary care: a narrative reviewBruce Bode, Aaron King, David Russell-Jones, et al.
Current Medical Research and Opinion|September 22, 2022
Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial diseaseAaron King, Jigar Rajpura, Yuanjie Liang, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|December 24, 2025
Clinician Guidance on the Benefits of Healthy Nutrition and Increased Physical Activity for People With Type 2 Diabetes Following Glucagon-Like Peptide 1 Receptor Agonist InitiationPamela Kushner, Carlos Campos, Aaron King, et al.
Membranes|December 23, 2022
Separation of Neodymium (III) and Lanthanum (III) via a Flat Sheet-Supported Liquid Membrane with Different Extractant-Acid SystemsLin Li, Ben Yu, Krystal Davis, et al.
Tissue Engineering. Part C, Methods|February 17, 2009
Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiationAllan Mishra, Padmaja Tummala, Aaron King, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Theoretical Biology|December 19, 2009
Consequential classes of resources: Subtle global bifurcation with dramatic ecological consequences in a simple population modelJohn Vandermeer, Aaron King
Clinical Diabetes : a Publication of the American Diabetes Association|April 24, 2023
Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes-So Why Is Their Uptake So Low?Aaron King, Eden M Miller
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 7, 2023
Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP-4i) in US Adults with Type 2 DiabetesXi Tan, Yuanjie Liang, Cory Gamble, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|December 24, 2025
Management of Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease Risk in People With Type 2 Diabetes: Collaborative Care Plans for Primary Care Physicians Using Effective Communication StylesCarlos Campos, Aaron King, Eden Miller, et al.
Postgraduate Medicine|September 30, 2024
Advances in insulin: a review of icodec as a novel once-weekly treatment for type 2 diabetesJavier Morales, Aaron King, Sean Oser, et al.
Annals of Medicine|June 29, 2021
Leveraging advances in diabetes technologies in primary care: a narrative reviewBruce Bode, Aaron King, David Russell-Jones, et al.
Current Medical Research and Opinion|September 22, 2022
Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial diseaseAaron King, Jigar Rajpura, Yuanjie Liang, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|December 24, 2025
Clinician Guidance on the Benefits of Healthy Nutrition and Increased Physical Activity for People With Type 2 Diabetes Following Glucagon-Like Peptide 1 Receptor Agonist InitiationPamela Kushner, Carlos Campos, Aaron King, et al.
Membranes|December 23, 2022
Separation of Neodymium (III) and Lanthanum (III) via a Flat Sheet-Supported Liquid Membrane with Different Extractant-Acid SystemsLin Li, Ben Yu, Krystal Davis, et al.
Tissue Engineering. Part C, Methods|February 17, 2009
Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiationAllan Mishra, Padmaja Tummala, Aaron King, et al.
Pageof 3